Leadership

Board of Directors of the BayBio Institute:

  • Nola Masterson, Science Futures. Chairwoman
  • Jeff Peterson, Target Discovery. Vice Chairman
  • Frederick J. Dorey, Esq., Cooley Godward. Secretary
  • Nandini Tandon, MDS Capital. Treasurer
  • Warren Browner, California Pacific Medical Center.
  • Joe Fernekes, City of South San Francisco.
  • Steve Sawyer, Woodruff Sawyer Insurance.
  • Sergio Garcia, Fenwick and West.
  • Robert Lee Kilpatrick, Technology Vision Group.
  • Douglas Crawford, UCSF QB3.
  • Elaine Johnson, Bio Link.
  • Steve Bengston, Price Waterhouse Coopers
  • Michael Alvarez, Stanford University
  • Andrea Cohen, Esq., Nixon Peabody
  • Helyn Dahle, Cell Genesys
  • Derek Dowsett, CPA, Moss-Adams
  • Moira Gunn, PhD, BioTech Nation
  • Jerry Iwata, Comerica Bank
  • James Kovach, MD, JD, Buck Institute for Ageing Research
  • Anna Williamson, PhD, Genentech

Staff of the BayBio Institute:

  • President: Matthew M. Gardner
  • Executive Director: Rob Gamble
  • Manager, Marketing & Communications: Jed Godsey

Directors emeritus
  • Ronald E. Cape, Ph.D.
    Co-Founder, Cetus Corp. and Biotech Investor
  • Brian C. Cunningham, Esq.
    Chief Executive Officer, Dao-Gen, Inc.
  • Stephen Dahms, Ph.D.
    President and Chief Executive Officer, Mann Foundation, and Former Director, California State Universities Program for Education & Research in Biotechnology (CSUPERB)
  • Corey Goodman
    Renovis.
  • Victoria Hale
    Institute for OneWorld Health.
  • Paul Heiden, Ph.D.
    Former Senior Vice President of Bayer Biologicals, Bayer HealthCare Division
  • Regis Kelly
    QB3 Institute.
  • Jennie Mather
    Raven Biotechnologies.
  • Edward Penhoet, Ph.D.
    Co-Founder, Chiron Corporation and President, Gordon and Betty Moore Foundation
  • Glen Y. Sato
    Partner, Cooley Godward and Former Senior Vice President & Chief Financial Officer, Protein Design Labs, Inc.
  • Jane Shaw
    Former CEO, Aerogen Corporation and Former CEO, ALZA Corporation
  • Brad Vale, Ph.D., DVM
    Vice President, Johnson & Johnson Development Corporation